Cassava Sciences reported $0 in Debt for its fiscal quarter ending in December of 2024.




Debt Change Date
Abbott USD 13.44B 195M Jun/2025
Amgen USD 56.2B 1.18B Jun/2025
Biogen USD 6.59B 296.8M Jun/2025
Cassava Sciences USD 0 0 Dec/2024
Eisai JPY 187.52B 31.58B Mar/2025
Eli Lilly USD 39.9B 1.39B Jun/2025
Geron USD 121.84M 3.12M Jun/2025
J&J USD 52.25B 15.62B Mar/2025
Merck USD 34.84B 2.27B Mar/2025
Novartis USD 31.27B 12M Mar/2025
Pfizer USD 60.93B 1.18B Jun/2025
Roche Holding CHF 34.44B 5.23B Jun/2024